Science is hard. Repeating other labs' findings is even harder.
That's particularly true in the life sciences, where biologists and
researchers manually run sophisticated experiments fraught with
variables such as water purity, humidity or subtle differences in
equipment.
"Biologists do almost everything by hand and
there's a lot of variation in experiments from lab to lab," said Ethan
Perlstein, founder and CEO of Perlstein Lab, a San Francisco-based
biotech startup working to discover drugs to fight rare genetic
diseases.
"I want to be able to do science in a way that's auditable and scalable, and the data is repeatable, pristine and good."
Emerald Therapeutics thinks its Emerald Cloud Lab, dubbed ECL-1, could
deliver just what Perlstein ordered. That's because ECL-1 lets
scientists remotely conduct more than 40 different standard experiment
types on $3 million worth of lab equipment, including DNA synthesizers,
mass spectrometers for separating and measuring the weight of charged
particles, and advanced microscopes. All similar equipment in the 15,000
square foot facility is perfectly identical, down to the type and
length of tubing and pipes. Automated robots perform the tests, removing
the human element from the equation.
Other startups offer similar science labs in the cloud. DNAnexus provides tools to store, manage and analyze the enormous amount of data generated by genome sequencing. Transcriptic
also touts its automated robotics and controlled lab environment, but
it handles fewer than 20 experiments, compared with ECL's 40.
In effect, Emerald and companies like it aim to become the biosciences
version of Amazon Web Services. Just as AWS pared the cost of
developing commercial software, labs in the cloud may change the
economics of life sciences exploration.
The average cost per experiment run by ECL-1, for example, is $25.
"We want to be the Amazon Prime of experiments, starting within 48
hours of the order," Brian Frezza, Emerald Therapeutics' co-founder and
co-CEO, said from the company's offices in South San Francisco, Calif.
Instead of leasing computer servers by the hour, as Amazon Web
Services does, Emerald and its rival startups rent out robots and
precisely calibrated instrumentation -- with the added benefit of
providing an auditable data trail.
"Having robots
handle experiments on exactly the same equipment, in exactly the same
environment, will always be superior to two pairs of hands," said
Perlstein,"It's just objectively better to have fully auditable and
automated experiments."
Best friends since grade school, Brian Frezza (left) and DJ Kleinbaum co-founded Emerald Therapeutics in 2010.
Emerald Therapeutics
The ramifications could be enormous. Consider: In 2011, researchers at
German pharmaceutical giant Bayer HealthCare reported they could replicate only one-third of 67 key studies
published in top science journals. The next year Amgen's former head of
global cancer research told Nature magazine that his team failed to reproduce the findings of 47 out of 53 "landmark" studies
the pharmaceutical company wanted to use in its drug development work.
Variables in equipment and environment could have contributed to their
issues.
Having reproducible results isn't the only
potential boon from labs in the cloud. There's also a financial
advantage, since modern labs buy equipment costing anywhere from
$100,000 to $240,000 per piece, which they use for perhaps 10 percent of
their research.
"This sort of experiment as a service
is interesting because it helps avoid the huge setup costs of buying the
equipment as well as finding someone skilled enough to understand and
configure everything -- all before you can even run your first
experiment," said Frank Gillett, an analyst with Forrester Research.
"Now you can reduce the time it takes to complete the experiment and
reduce the cost of the experiment itself," said Gillett.
Stephen Wolfram, developer of Mathematica computational
software and the Wolfram programming language (and one of the youngest
recipients of the MacArthur Fellowship), sees an even bigger benefit:
labs like ECL-1 let scientists explore the biggest questions.
Wolfram calls it a "top down" vs. "bottom up" approach to scientific
discovery. A top-down approach, for example, lets researchers design
whatever experiments will "get at some larger truth about biology." In a
bottom-up approach, however, scientists decide what to explore based on
the resources they have at their disposal. While both are valid, the
top-down way of thinking leads to big discoveries faster. Wolfram is
also an adviser to Emerald Therapeutics.
With ECL-1,
scientists "can be running any experiment remotely within 24 hours, all
without having to invest months of time, dedicating large number of
staff members, and obtaining millions of dollars in fixed cost equipment
to bring these experiments online," Wolfram said in an emailed
statement.
"Life scientists can go back to a focus on
how to answer the largest remaining questions in chemistry and biology
rather then spend all of their time focused on becoming professional
fundraisers and managers of large organizations," Wolfram said.
Emerald expects to offer more than 100 experiments -- or 100 percent
of all life science tests -- within the next 18 months. "We won't
consider ourselves in full production until we offer 100 percent of all
the available lab tests," said DJ Kleinbaum, Emerald's other co-founder
and co-CEO. Best friends since grade school, Kleinbaum holds a PhD in
organic chemistry from Stanford University; Frezza earned his PhD in
chemical biology from The Scripps Research Institute. They founded
Emerald in 2010.
For his part, Perlstein is happy to
have access to ECL's available tests, conducted with robotic precision.
"This is the beginning of the transformation to replicable scientific
methods," said Perlstein. "Science isn't science until it's reproduced."
Science is hard. Repeating other labs' findings is even harder.
That's particularly true in the life sciences, where biologists and
researchers manually run sophisticated experiments fraught with
variables such as water purity, humidity or subtle differences in
equipment.
"Biologists do almost everything by hand and
there's a lot of variation in experiments from lab to lab," said Ethan
Perlstein, founder and CEO of Perlstein Lab, a San Francisco-based
biotech startup working to discover drugs to fight rare genetic
diseases.
"I want to be able to do science in a way that's auditable and scalable, and the data is repeatable, pristine and good."
Emerald Therapeutics thinks its Emerald Cloud Lab, dubbed ECL-1, could
deliver just what Perlstein ordered. That's because ECL-1 lets
scientists remotely conduct more than 40 different standard experiment
types on $3 million worth of lab equipment, including DNA synthesizers,
mass spectrometers for separating and measuring the weight of charged
particles, and advanced microscopes. All similar equipment in the 15,000
square foot facility is perfectly identical, down to the type and
length of tubing and pipes. Automated robots perform the tests, removing
the human element from the equation.
Other startups offer similar science labs in the cloud. DNAnexus provides tools to store, manage and analyze the enormous amount of data generated by genome sequencing. Transcriptic
also touts its automated robotics and controlled lab environment, but
it handles fewer than 20 experiments, compared with ECL's 40.
In effect, Emerald and companies like it aim to become the biosciences
version of Amazon Web Services. Just as AWS pared the cost of
developing commercial software, labs in the cloud may change the
economics of life sciences exploration.
The average cost per experiment run by ECL-1, for example, is $25.
"We want to be the Amazon Prime of experiments, starting within 48
hours of the order," Brian Frezza, Emerald Therapeutics' co-founder and
co-CEO, said from the company's offices in South San Francisco, Calif.
Instead of leasing computer servers by the hour, as Amazon Web
Services does, Emerald and its rival startups rent out robots and
precisely calibrated instrumentation -- with the added benefit of
providing an auditable data trail.
"Having robots
handle experiments on exactly the same equipment, in exactly the same
environment, will always be superior to two pairs of hands," said
Perlstein,"It's just objectively better to have fully auditable and
automated experiments."
Best friends since grade school, Brian Frezza (left) and DJ Kleinbaum co-founded Emerald Therapeutics in 2010.
Emerald Therapeutics
The ramifications could be enormous. Consider: In 2011, researchers at
German pharmaceutical giant Bayer HealthCare reported they could replicate only one-third of 67 key studies
published in top science journals. The next year Amgen's former head of
global cancer research told Nature magazine that his team failed to reproduce the findings of 47 out of 53 "landmark" studies
the pharmaceutical company wanted to use in its drug development work.
Variables in equipment and environment could have contributed to their
issues.
Having reproducible results isn't the only
potential boon from labs in the cloud. There's also a financial
advantage, since modern labs buy equipment costing anywhere from
$100,000 to $240,000 per piece, which they use for perhaps 10 percent of
their research.
"This sort of experiment as a service
is interesting because it helps avoid the huge setup costs of buying the
equipment as well as finding someone skilled enough to understand and
configure everything -- all before you can even run your first
experiment," said Frank Gillett, an analyst with Forrester Research.
"Now you can reduce the time it takes to complete the experiment and
reduce the cost of the experiment itself," said Gillett.
Stephen Wolfram, developer of Mathematica computational
software and the Wolfram programming language (and one of the youngest
recipients of the MacArthur Fellowship), sees an even bigger benefit:
labs like ECL-1 let scientists explore the biggest questions.
Wolfram calls it a "top down" vs. "bottom up" approach to scientific
discovery. A top-down approach, for example, lets researchers design
whatever experiments will "get at some larger truth about biology." In a
bottom-up approach, however, scientists decide what to explore based on
the resources they have at their disposal. While both are valid, the
top-down way of thinking leads to big discoveries faster. Wolfram is
also an adviser to Emerald Therapeutics.
With ECL-1,
scientists "can be running any experiment remotely within 24 hours, all
without having to invest months of time, dedicating large number of
staff members, and obtaining millions of dollars in fixed cost equipment
to bring these experiments online," Wolfram said in an emailed
statement.
"Life scientists can go back to a focus on
how to answer the largest remaining questions in chemistry and biology
rather then spend all of their time focused on becoming professional
fundraisers and managers of large organizations," Wolfram said.
Emerald expects to offer more than 100 experiments -- or 100 percent
of all life science tests -- within the next 18 months. "We won't
consider ourselves in full production until we offer 100 percent of all
the available lab tests," said DJ Kleinbaum, Emerald's other co-founder
and co-CEO. Best friends since grade school, Kleinbaum holds a PhD in
organic chemistry from Stanford University; Frezza earned his PhD in
chemical biology from The Scripps Research Institute. They founded
Emerald in 2010.
For his part, Perlstein is happy to
have access to ECL's available tests, conducted with robotic precision.
"This is the beginning of the transformation to replicable scientific
methods," said Perlstein. "Science isn't science until it's reproduced."
Google is suspending a service that allowed members of the public to contribute to its maps, following vandalism.
Map Maker allowed users to draw features, adding roads, rivers, green spaces and local businesses.
But some edits, such as an image of its Android mascot urinating on an Apple logo, were not as welcome.
Google said that the shutdown is "temporary" but admitted that it will take
Google is suspending a service that allowed members of the public to contribute to its maps, following vandalism.
Map Maker allowed users to draw features, adding roads, rivers, green spaces and local businesses.
But some edits, such as an image of its Android mascot urinating on an Apple logo, were not as welcome.
Google said that the shutdown is "temporary" but admitted that it will take
Apple is on track to bring out a giant iPad later this year that
would rival, in size at least, Microsoft’s 12-inch Surface Pro 3,
according to an analyst.
“We expect it to be part of the iPad refresh in October,” Rhoda
Alexander, director of Tablet and Monitor Research at marketing research
firm IHS Technology,
Apple is on track to bring out a giant iPad later this year that
would rival, in size at least, Microsoft’s 12-inch Surface Pro 3,
according to an analyst.
“We expect it to be part of the iPad refresh in October,” Rhoda
Alexander, director of Tablet and Monitor Research at marketing research
firm IHS Technology,
One type of cover music you may not have heard of is called FDD, or floppy disk drive music.
Yes, floppy disks. Remember those? The hardware has been long tossed
aside, but a legion of technophiles have resurrected the old PC
components to produce music.
YouTube user Arganalth has an amazing version of Nirvana's 'Smells Like Teen Spirit'. Gigawipf uses 14 floppy disk drives and a hard drive to eek out Soft Cell's 'Tainted Love'. And for the past three years, Anand Jain, known on YouTube as MrSolidSnake745, has been using floppy disk drives to c
His 2-minute long floppy disk drive version of 'The Game of Thrones' theme has gotten over 1.8 million views on YouTube since he first published it in 2012.
One type of cover music you may not have heard of is called FDD, or floppy disk drive music.
Yes, floppy disks. Remember those? The hardware has been long tossed
aside, but a legion of technophiles have resurrected the old PC
components to produce music.
YouTube user Arganalth has an amazing version of Nirvana's 'Smells Like Teen Spirit'. Gigawipf uses 14 floppy disk drives and a hard drive to eek out Soft Cell's 'Tainted Love'. And for the past three years, Anand Jain, known on YouTube as MrSolidSnake745, has been using floppy disk drives to c
His 2-minute long floppy disk drive version of 'The Game of Thrones' theme has gotten over 1.8 million views on YouTube since he first published it in 2012.
As Microsoft made clear last year by skipping Windows 9 when
going from Windows 8 to Windows 10, Windows version numbers are an
arbitrary thing.
That's why all this talk about Windows 10, the upcoming version of Microsoft's operating system, being the "last version of Windows" is a "nothing to see here" moment.
Many of us Microsoft watchers had been saying that Threshold (Windows 10) would be the last major version of Windows
for months, if not a year. (Windows 10 is due to start rolling out
around the middle of the year.) Microsoft Developer Evangelist Jerry
Nixon said the same thing last week at Ignite in a session titled "Tiles, Notifications and Action Center."
As Microsoft made clear last year by skipping Windows 9 when
going from Windows 8 to Windows 10, Windows version numbers are an
arbitrary thing.
That's why all this talk about Windows 10, the upcoming version of Microsoft's operating system, being the "last version of Windows" is a "nothing to see here" moment.
Many of us Microsoft watchers had been saying that Threshold (Windows 10) would be the last major version of Windows
for months, if not a year. (Windows 10 is due to start rolling out
around the middle of the year.) Microsoft Developer Evangelist Jerry
Nixon said the same thing last week at Ignite in a session titled "Tiles, Notifications and Action Center."
The deal is part of Verizon's(VZ, Tech30)
new focus on digital and video platforms, as well as its connected
device network, which it calls "Internet of Things," the
telecommunications company said
The deal is part of Verizon's(VZ, Tech30)
new focus on digital and video platforms, as well as its connected
device network, which it calls "Internet of Things," the
telecommunications company said
Consumers in China -- the world's largest smartphone market
-- hit the pause button during the first quarter, and that has
implications for how companies like Apple and Samsung go about their
business there.
Those two companies headed in opposite
directions during the first quarter, with Apple's market share in China
soaring after the arrival of its iPhone 6 and iPhone 6 Plus, and Samsung's share sagging just as dramatically.
Consumers in China -- the world's largest smartphone market
-- hit the pause button during the first quarter, and that has
implications for how companies like Apple and Samsung go about their
business there.
Those two companies headed in opposite
directions during the first quarter, with Apple's market share in China
soaring after the arrival of its iPhone 6 and iPhone 6 Plus, and Samsung's share sagging just as dramatically.
Windows 10 is going to be the last major revision of the operating system.
Jerry
Nixon, a Microsoft development executive, said in a conference speech
this week that Windows 10 would be the "last version" of the dominant
desktop software.
His comments were echoed by Microsoft which said it would update Windows in future in an "ongoing manner".
Instead of new stand-alone versions, Windows 10 would be improved in regular instalments, the firm said.
Mr Nixon made his comments during Microsoft's Ignite conference held in Chicago this week.
In a statement, Microsoft said Mr Nixon's comments reflected a change in the way that it made its software.
"Windows
will be delivered as a service bringing new innovations and updates in
an ongoing manner," it said, adding that it expected there to be a "long
future" for Windows.
Windows 10 is going to be the last major revision of the operating system.
Jerry
Nixon, a Microsoft development executive, said in a conference speech
this week that Windows 10 would be the "last version" of the dominant
desktop software.
His comments were echoed by Microsoft which said it would update Windows in future in an "ongoing manner".
Instead of new stand-alone versions, Windows 10 would be improved in regular instalments, the firm said.
Mr Nixon made his comments during Microsoft's Ignite conference held in Chicago this week.
In a statement, Microsoft said Mr Nixon's comments reflected a change in the way that it made its software.
"Windows
will be delivered as a service bringing new innovations and updates in
an ongoing manner," it said, adding that it expected there to be a "long
future" for Windows.
Adsense Affiliate Amazon Android App Apple Blogger Gist Brain Box Business Cars celebrity Education Facebook Featured Free stuff google hark How-To Instagram Internet Konga LG Mac Book Microsoft mobile Money Making Tips. my products Naija News NCC Nexus Online Shopping pc Ranks Review Samsung SEO smartphone Social Network Software Tech News Updates Technology. Template Twitter wWw YouTube